Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia
Clinical trial NCT04160260 · COMPLETED
Trial details
- NCT number
- NCT04160260
- Sponsor
- Paratek Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-28
- Primary completion
- 2020-03-23
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.